The scoping study numbers don't apply to what they are doing now..different method of development. Higher grades first, simpler processing flowsheet, better metal recoveries, much less capex needed initially. The PFS will bring it all out in more detail of course but their new work is aimed at making or possibly already made $900 USD Pd profitable. According to recent statistics, EV's sales are dropping in favour of hybrids.
CHN
chalice mining limited
Add to My Watchlist
9.73%
!
$1.81

CHN chart, page-9217
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.81 |
Change
0.160(9.73%) |
Mkt cap ! $702.1M |
Open | High | Low | Value | Volume |
$1.73 | $1.86 | $1.71 | $10.02M | 5.567M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 2500 | $1.80 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.81 | 11173 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 820 | 1.765 |
2 | 5170 | 1.760 |
8 | 41983 | 1.750 |
1 | 5000 | 1.745 |
1 | 1000 | 1.740 |
Price($) | Vol. | No. |
---|---|---|
1.805 | 11173 | 1 |
1.810 | 11173 | 1 |
1.820 | 39000 | 2 |
1.825 | 2045 | 1 |
1.835 | 1831 | 2 |
Last trade - 16.11pm 27/06/2025 (20 minute delay) ? |
Featured News
CHN (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online